相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Stacey L. Demento et al.
BIOMATERIALS (2012)
Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies
Jacopo Mariotti et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Long-Term Maintenance of Polysaccharide-Specific Antibodies by IgM-Secreting Cells
Jeremy B. Foote et al.
JOURNAL OF IMMUNOLOGY (2012)
Vaccination with Liposomal Leishmanial Antigens Adjuvanted with Monophosphoryl Lipid-Trehalose Dicorynomycolate (MPL-TDM) Confers Long-Term Protection against Visceral Leishmaniasis through a Human Administrable Route
Rajesh Ravindran et al.
MOLECULAR PHARMACEUTICS (2012)
Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens
Antu K. Dey et al.
EXPERT REVIEW OF VACCINES (2011)
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Robert L. Atmar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection
Zili Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice
SriJayaprakash Babu Uppada et al.
VACCINE (2011)
Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine
Lissette S. Velasquez et al.
VACCINE (2011)
An Intranasally Delivered Toll-Like Receptor 7 Agonist Elicits Robust Systemic and Mucosal Responses to Norwalk Virus-Like Particles
Lissette S. Velasquez et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
The controversial relationship between NLRP3, alum, danger signals and the next-generation adjuvants
Roberto Spreafico et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Norwalk virus-like particles as vaccines
Melissa Herbst-Kralovetz et al.
EXPERT REVIEW OF VACCINES (2010)
Serological Correlate of Protection against Norovirus-Induced Gastroenteritis
Amanda Reeck et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Heterotypic Humoral and Cellular Immune Responses following Norwalk Virus Infection
Lisa C. Lindesmith et al.
JOURNAL OF VIROLOGY (2010)
Enhanced humoral and cellular immune responses after sublingual immunization against human papillomavirus 16 L1 protein with adjuvants
Hee-Jeong Cho et al.
VACCINE (2010)
TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants
Sarah C. Higgins et al.
Current Infectious Disease Reports (2010)
Unleashing the therapeutic potential of NOD-like receptors
Kaoru Geddes et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Dendritic cell subtypes as primary targets of vaccines:: the emerging role and cross-talk of pattern recognition receptors
Szilvia Benko et al.
BIOLOGICAL CHEMISTRY (2008)
NOD-like receptors (NLRs):: bona fide intracellular microbial sensors
Michael H. Shaw et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
Mirjam Kool et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth et al.
NATURE (2008)
NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2
Yibin Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Bacterial cell walls, innate immunity and immunoadjuvants
Jack L. Strominger
NATURE IMMUNOLOGY (2007)
Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa
E Cox et al.
VETERINARY RESEARCH (2006)
MDP and other muropeptides - direct and synergistic effects on the immune system
S Traub et al.
JOURNAL OF ENDOTOXIN RESEARCH (2006)
Synergistic effect of Nod1 and Nod2 Agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells
H Tada et al.
INFECTION AND IMMUNITY (2005)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
Nods and 'intracellular' innate immunity
M Viala et al.
COMPTES RENDUS BIOLOGIES (2004)
The role of Toll-like receptors and Nod proteins in bacterial infection
DJ Philpott et al.
MOLECULAR IMMUNOLOGY (2004)
Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment
GM Bahr et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide
GM Bahr
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses
RA Guerrero et al.
JOURNAL OF VIROLOGY (2001)
Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide
V Vidal et al.
IMMUNOLOGY (2001)
The synthetic immunomodulator Murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells
ECA Darcissac et al.
JOURNAL OF VIROLOGY (2000)
分享论文
